http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-367095-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65515
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655
filingDate 1969-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1971-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-367095-A1
titleOfInvention A PROCEDURE FOR THE PREPARATION OF ACID (CIS-1,2-EPO-XIPROPIL) -PHOSPHONIC AND ESTERS OR SALTS OF THE SAME.
abstract (Cis- 1 ,2-epoxypropyl) phosphonic acid or an ester or salt thereof is obtained by eliminating S0 2 , S0 3 , CO or N 2 from a cis-compound of the formula wherein each R is H or a substituted or unsubstituted aliphatic, cycloaliphatic, araliphatic or aromatic hydrocarbyl or heterocyclic radical, the two R groups being similar or dissimilar and Z is or from a salt of such a compound in which at least one of R is H. Suitable salts are e.g. the mono- and di- Na or K salts, Ca, Mg, Ag, Fe and NH 4 salts, and amine salts including salts of biologically active amines such as erythromycin or novobiscin. The elimination of Z may be effected by pyrolyzing or heating, e.g. at above 80 C., or by U.V. light. In carrying out the pyrolysis the starting material can be heated directly or may be dissolved in an inert solvent or suspended in a suspending agent, e.g. a mineral oil and the reaction is generally complete when no more S0 2 , S0 3 , CO or N 2 is evolved from the reaction mixture. The treatment with U.V. light such as that produced by a mercury vapour lamp may be conducted on a solution or suspension of the starting material which may have been sensitized to U.V. light by the addition of a photosensitizing agent such as benzophenone or acetophenone and the irradiation is suitably conducted at from -10 to 50 C. The starting material may be the ( ) cis isomer or a cis/trans mixture and the corresponding product isomer is obtained. A mixture of the cis and trans isomers of the starting material can be separated into the cis and trans isomers by known techniques and any ( ) trans isomer of the product can be converted to the ( ) cis isomer by U.V. light. If the starting material is an ester the resulting ester product can be converted to the free acid or salt thereof by acid or base hydrolysis, by enzymatic or light catalysed hydrolysis, by hydrolysis via a trimethyl silyl derivative, or by hydrogenolysis or by treatment with a sodium tertiary amine. The racemic end mixture may be resolved into the optically active forms. The ( ) compounds have antibacterial properties being especially useful in salt form. The starting materials (I) in which Z is -SO 2 - can be obtained by reacting a compound of the formula with a sulphide, e.g. sodium sulphide, to form a compound of the formula which is then oxidized, e.g. with potassium permanganate or H 2 0 2 to form the desired product. Compounds (I) in which Z is -O-SO 2 - can be obtained by reacting CH 3 CH(OH)S0 3 Na with O=CH-P(O)(OR) 2 in the presence of acetic anhydride followed by addition of a base. Compounds (I) in which Z is CO and R is H can be obtained by converting phosphonoacetic acid e.g. by treatment with thionyl chloride and then with bromine to form Cl 2 -P(O)CHBrCOCl which is diazotized with diazoethane to form the 3-diazo compound Cl 2 P(O)CHBrCOC(CH 3 ) = N 2 which is then cyclized by treatment with an aqueous solution of a carbonate and an acid, e.g. acetic acid. Compounds (I) in which Z is N=N are obtained by reacting acetaldehyde with a hydroxymethyl phosphonic acid compound and a chlorinating agent to form CH 3 CHClOCH 2 P(O)(OR) 2 , reacting the latter with a free radical halogenating agent such as t-butyl hypochlorite at about 40 C. to form CH 3 CHClOCH(Cl)P(O)(OR) 2 which is reacted with hydrazine to yield a product of the formula and finally oxidizing the latter, e.g. by treatment with mercuric oxide or cupric chloride in a solvent such as an ether or hydrocarbon. The formyl - phosphonate compounds O = CHP(O)(OR) 2 may be obtained by ozonizing vinyl phosphonic acid or ester or salt thereof.
priorityDate 1968-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407330845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415747309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415158188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23002186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415989640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425258636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453530231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449170258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918

Total number of triples: 63.